SRNE - Sorrento R&D event for COVID-19 on October 13
Sorrento Therapeutics (SRNE) will host a R&D Day conference call and webcast on October 13, 2020 focusing on its multi-modal approach to COVID-19. Management will highlight strategic advancement, challenges, key pipeline updates and drivers of future growth in the COVID-19 space.R&D Day Agenda: Clinical stage products (cleared Phase 1 or Phase 2); pre-clinical stage products of high interest and diagnostics.See below Company's COVID-19 Programs:
For further details see:
Sorrento R&D event for COVID-19 on October 13